Mary Stuart

Mary is a Pharmaceutical Physician specialising in oncology, with specific expertise in breast cancer and with over two decades of experience in large multinational pharmaceutical companies. She was the clinical lead for the set up of the positive MonarchE adjuvant breast cancer study for Eli Lilly and the successful Falcon, Olympiad and Olympia studies for AstraZeneca , and was the Breast Cancer Disease Area expert for AstraZeneca. Previously Mary was clinical lead for the early pertuzumab breast cancer development for Roche.